CytoMed Therapeutics Limited (GDTC) Total liabilities 2024–2025
CytoMed Therapeutics Limited (GDTC) total liabilities at each fiscal year-end, per SEC filings.
$1.1MFY2025 · since FY2024: $806,404 → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1M | +38.9% |
| FY2024 | $806,404 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GDTC financial trends
GDTC RevenueGDTC Net incomeGDTC Net marginGDTC Gross profitGDTC Gross marginGDTC Operating incomeGDTC Operating marginGDTC Operating cash flowGDTC Free cash flowGDTC Capital expendituresGDTC Return on equityGDTC Stock buybacksGDTC Dividends paidGDTC Total assetsGDTC Shareholders’ equityGDTC overview →